Document ID: chunk:federal_register_of_legislation:F2020C01070:clause:3_11
Version: federal_register_of_legislation:F2020C01070
Segment Type: clause
Provision Reference: sch 3 cl 11
Character Range: 14151–15271

11  Dissolution
  If:
           (a)    a tablet or capsule is a registered good that:
           (i) does not contain folic acid; or
           (ii) is not a modified-release tablet, chewable tablet, effervescent tablet, dispersible tablet or modified-release capsule; and
           (b)    the applicable monograph that is applied to the tablet or capsule does not specify a test for dissolution; and
           (c)    a default standard in relation to any active ingredient contained in that tablet or capsule specifies a dissolution test for the relevant dosage form;
then the dissolution test specified for the tablet or capsule is:
           (d)    the dissolution test specified in the default standard mentioned in paragraph (1)(c); or
           (e)    another dissolution test that is suitable for the tablet or capsule..
Note 1: A dissolution test is specified for tablets and capsules that are registered goods or listed goods, containing folic acid: see section 10.
Note 2: A dissolution test will always be specified in an applicable monograph for modified-release tablets and modified-release capsules.